EarningsQ2 2024 Earnings Report

Shield Therapeutics (1JS) Q2 2024 Earnings Report

2 Followers

DE:1JS Q2 2024 EPS Results

Actual EPS-€0.02

Consensus EPS―

Beat/Miss―

One Year Ago EPS-€0.02

Actual Revenue€11.17M

Expected Revenue€5.93M

Beat/MissBeat by +€5.24M

YoY Revenue Growth+172.93%

QuarterQ2 2024

Date09/04/2024

TimeBefore Open

Conference CallWednesday, September 4, 2024

DE:1JS Upcoming Earnings

Shield Therapeutics's next earnings date is estimated for April 29, 2027, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Apr 29, 2027	2026 (Q4)	- / -	-0.007	―
Aug 20, 2026	2026 (Q2)	- / 0.00	-0.009	―
Apr 09, 2026	2025 (Q4)	- / >-0.01	-0.017	60.00% (+0.01)
Aug 21, 2025	2025 (Q2)	- / >-0.01	-0.017	50.00% (<+0.01)
Apr 24, 2025	2024 (Q4)	-0.02 / -0.01	-0.019	31.82% (<+0.01)
Sep 04, 2024	2024 (Q2)	- / -0.02	-0.017	0.00% (0.00)
Apr 30, 2024	2023 (Q4)	- / -0.03	-0.139	81.51% (+0.11)
Sep 28, 2023	2023 (Q2)	- / -0.02	-0.048	64.29% (+0.03)
Apr 27, 2023	2022 (Q4)	- / -0.14	-0.063	-120.37% (-0.08)
Sep 08, 2022	2021 (Q4)	- / -0.05	-0.046	-5.66% (>-0.01)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed